There is a very small chance they are also at risk to have children with CTD
Altintas Dogan et al 75 experiment found that liraglutide significantly reduced body weight, decreased inflammatory markers such as IL-6 and MCP-1, increased exertional spirometry (FVC) and carbon monoxide diffusion capacity, and improved COPD assessment test scores, but no significant improvement in FEV1, FEV1/FVC, or 6-minute walk tests, suggesting the possibility that GLP-1RA may reduce inflammatory responses, improve lung function, and mitigate the degree of impaired health in patients with COPD
In addition to weight loss results, studies show improved quality of life for 40% to 50% of participants
Meta Pemivibart Meta Ravulizumab Meta Regdanvimab Meta SA58 Meta Sarilumab Meta Sipavibart Meta Sotrovimab Meta Tixagev../c
[DOI] [PubMed] [Google Scholar] 33.Szabo S
doi: 10.1016/j.jss.2012.06.024